The Norwegian Antibiotics for Pneumonia in Children Study

Summary

This study evaluates the effect of amoxicillin in the treatment of lower airway infections in preschool children. Half of the patients will receive amoxicillin, while the other half will receive placebo.

Conditions

• Pneumonia Childhood
• Lower Respiratory Tract Infection

Interventions

DRUG

Amoxicillin

Imacillin mixture

DRUG

Placebos

Placebo manufactured to mimic amoxicillin mixture (Imacillin)

Sponsors & Collaborators

• Ostfold Hospital Trust

  collaborator OTHER

• Helse Stavanger HF

  collaborator OTHER_GOV

• Haukeland University Hospital

  collaborator OTHER

• Alesund Hospital

  collaborator OTHER

• St. Olavs Hospital

  collaborator OTHER

• Nordlandssykehuset HF

  collaborator OTHER

• University Hospital of North Norway

  collaborator OTHER

• University Hospital, Akershus

  collaborator OTHER

• Norwegian Institute of Public Health

  collaborator OTHER_GOV

• Klinbeforsk

  collaborator OTHER

• Oslo University Hospital

  lead OTHER

Principal Investigators

• Håvard O Skjerven · Oslo University Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

12 Months

Max Age

59 Months

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-03-07

Primary Completion

2020-05-31

Completion

2020-12-31

Countries

• Norway

Study Locations